Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

MiMedx Group (Nasdaq: MDXG) announces CEO Timothy R. Wright and CFO Peter M. Carlson will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13 at 4:30 PM EST. Institutional investors wishing to connect with management can contact their J.P. Morgan representatives.

Interested parties can access the live webcast on the company's website, with a replay available for 30 days post-presentation. MiMedx specializes in advanced wound care, providing over two million allografts using its proprietary PURION® process.

MARIETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will present at the 39^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13^th at 4:30 PM EST. Institutional investors interested in meeting with management during the conference may reach out to their J.P. Morgan representative.

Investors and other interested parties may access the live webcast on the Events page of the Investors section of the Company’s website or by clicking here.  A replay of the webcast will be available for 30 days on the Company’s website at www.mimedx.com following the conclusion of the presentation.

About MiMedx
MiMedx^® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION^® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contacts:
Investors
Jack Howarth
404-360-5681
investorrelations@mimedx.com

 

FAQ

What key event is MiMedx participating in on January 13, 2021?

MiMedx will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 4:30 PM EST.

Who are the presenters from MiMedx at the J.P. Morgan Conference?

The presenters from MiMedx at the conference are CEO Timothy R. Wright and CFO Peter M. Carlson.

How can investors access the MiMedx presentation at the J.P. Morgan Conference?

Investors can access the live webcast on the Investors section of MiMedx's website.

Is there a replay available for the MiMedx conference presentation?

Yes, a replay of the MiMedx presentation will be available for 30 days on their website after the event.

What products does MiMedx offer in the healthcare sector?

MiMedx offers advanced wound care products, specifically human placental tissue allografts, utilizing proprietary processes.